Join CSHP's Special COVID-19 Pharmacy Specialty Network

In an effort to share information and best hospital pharmacy practices regarding COVID-19, the Canadian Society of Hospital Pharmacists has set-up a special open access (free to members and non-members) Pharmacy Specialty Network (PSN). 

Register now to join the COVID-19 PSN here:

Already registered for QID? Access the COVID-19 PSN here:

CSHP COVID-19 Free Webinar Series

Free to members and non-members. You must register to attend.
Please take note that all sessions will be recorded and posted on this page as they become available.
Suggestions for other webinars and presenter are welcome – please send to Christina Adams.

Panel - What are the Treatment Options for COVID-19?   covid   Register Thursday, April 9, 2020, 7:00 pm EDT
Adapting Hospital Pharmacy Practice During a Pandemic  covid . Register Tuesday, April 7, 2020, 1:00 pm EDT

Evaluating Evidence for Emerging Therapies during a Pandemic

pdf.pngSlides video.png  View recording April 2, 2020

COVID19: Managing Autoimmune, Psychiatric and Trauma Responses

pdf.pngSlides video.png  View recording March 31, 2020
Implementing Hospital Telepharmacy: Review of CSHP’s Telepharmacy Guidelines pdf.pngSlides video.png  View recording March 26, 2020
Going Nsane over NSAIDs: Evaluation of the evidence behind the rejection of ibuprofen in management of COVID-19 pdf.pngSlides video.png  View recording March 24, 2020

CSHP COVID-19 webinar series made free and freely available thanks to these partners.


CSHP Branch Contributions

CSHP-BC COVID-19 What Pharmacists Know Now: Free Short Video Series

Role of Statins 
Presented by Ricky Turgeon, BSc(Pharm), ACPR, PharmD

video.png  View recording

(14 minutes)

April 3, 2020
COVID-19 Virus Stability and Transmission
Presented by Kelly Grindrod, BScPharm, PharmD, MSc

video.png  View recording

(18 minutes)

March 30, 2020
Should we avoid corticosteroids?
Presented by Megan Harbin, BSc(Pharm), PharmD, ACPR

video.png  View recording

(22 minutes)

March 27, 2020

Role of Hydroxychloroquine

Presented by Gregory Mah, PharmD

video.png  View recording

(19 minutes)

March 27, 2020
Should patients discontinue their ACE inhibitors and ARBs? Presented by Arden Berry, BSc, BSc(Pharm), PharmD, ACPR

video.png  View recording

(9 minutes)

March 25, 2020
Does ibuprofen worsen COVID-19 Infection? Presented by Doson Chua, BSc(Pharm), PharmD, FCSHP,  BCPS, BCCP

video.png  View recording

(5 minutes)

March 24, 2020


COVID-19 Patient Discharge Tips   covid

A CSHP Statement on COVID-19

See CSHP's full statement on COVID-19 here.


Care for patients is at the heart of the hospital pharmacy profession. During the pandemic, you put yourself at even higher risk than you normally experience in the course of your work. We acknowledge the dedication and professionalism that underscores your service to public health. We also see your humanity and the vulnerability inherent in that service and are here to support you through this journey.
~Tania Mysak, BSP, PharmD, CSHP President; Jody Ciufo, MBA, CSHP CEO

Additional Member Updates


We have partnered with all major pharmacy sector stakeholders to advocate on a number of fronts with several government agencies. In addition to contributing to pandemic response teams at various levels, CSHP signed on to an open letter to the Government of Canada, led by CPhA and co-signed by 16 other national and provincial organizations, that calls for Health Canada to recognize pharmacists as essential healthcare providers, with respect to the supply and allocation of PPE. CSHP is working with CPhA to craft evidence-based PPE best-practice recommendations.


CSHP members – pharmacists, pharmacy technicians, pharmacy students, interns and residents – insured with our preferred provider BMS are in good hands. Please review the COVID-19: Insurance Coverage Position Statement for details. A note for our retired members: If you return to work, you must purchase an active policy (and should check with your provincial regulatory body about registration to active status). Pro-rated fees are available for shorter terms between now and June 30, 2020. Learn more here.

Open Letter to Colleagues and Professionals re: COVID‐19 

A complete .pdf copy of CSHP member, Dr. Joel Lamoure's letter can be accessed here.


In a period of personal and professional uncertainty, and a seemingly endless wave of scary recent information, I wish to add a few thoughts and validations for my colleagues. I am speaking from 30 years of pharmacy including neurosurgical ICU, psychiatry practice and serving as the UNESCO Canadian Section Chief for medical bioethics. The number one paper that people accessed from my publications around the world this week was about Management of Panic Disorder, so I think it is time for me to weigh in. 
~Joel Lamoure RPh., DD., FASCP

Additional Tools and Resources for Hospital Pharmacy Teams

Social Media

Use #COVID19RX for treatments related to COVID-19


  • Updated Belguim COVID-19 guidelines include Hydroxychloroquine for confirmed mild/moderate cases. Access the guidelines in .pdf format here.
  • The Liverpool Drug Interaction Group (based at the University of Liverpool, UK), in collaboration with the University Hospital of Basel (Switzerland) and Radboud UMC (Netherlands), have produced various materials in .pdf format to aid the use of experimental agents in the treatment of COVID-19. Access the website with .pdf resources on COVID_19 here: COVID-19 Drug interactions.

Information from Health Canada

  • Special access to Remdesivir (March 16, 2020)
    Accès spécial au remdésivir (16 mars 2020)
    Update (March 23, 2020)
  • Guidance on exemptions for prescriptions of controlled substances under the CDSA and its Regulations (March 19, 2020)
    If permitted within the applicable provincial/territorial scopes of practice, the exemptions permit pharmacists to extend prescriptions; permit pharmacists to transfer prescriptions to other pharmacists; permit prescribers to issue verbal orders (i.e., over the phone) to extend or refill a prescription; and permit pharmacy employees to deliver prescriptions of controlled substances to patients’ homes or other locations where they may be (i.e., self isolating). View the exemptions in English or French.

UpToDate Coronavirus Topic

For clinicians at the front lines of the outbreak who are seeking the most current, evidence-based clinical decision support, the Coronavirus topic on UpToDate is available for free: English (worldwide access)

Public Health Agency of Canada

HealthCare Organizations

Resources for Re-familiarizing with Critical Care and Medical Emergencies   Newly-Added